Country: Japan
Language: English
Source: すりの適正使用協議会 RAD-AR Council, Japan
Etanercept (genetical recombination) [etanercept biosimilar 2]
Nichi-iko Pharmaceutical Co.,Ltd
Etanercept (genetical recombination) [etanercept biosimilar 2]
colorless to pale yellow and limpid injectable preparation
Drug Information Sheet("Kusuri-no-Shiori") Self-injection Published: 11/2019 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. BRAND NAME: ETANERCEPT BS 50MG PEN 1.0ML FOR S.C. INJ."NICHIIKO" ACTIVE INGREDIENT: Etanercept (genetical recombination) [etanercept biosimilar 2] DOSAGE FORM: colorless to pale yellow and limpid injectable preparation IMPRINT OR PRINT ON WRAPPING: EFFECTS OF THIS MEDICINE This medicine suppresses action of TNFα which is considered to cause abnormal immunity associated with various diseases to prevent the damage of joints and bones. It is usually used to treat rheumatoid arthritis. THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS MEDICINE.BE SURE TO TELL YOUR DOCTOR AND PHARMACIST. ・If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines or foods. If you have infection (sepsis, etc.) or congestive heart failure. If you have tuberculosis, demyelinating diseases (multiple sclerosis, etc.) or history of any of them. If you have a history of interstitial pneumonia. ・If you are pregnant or breastfeeding. ・If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE) ・ Your dosing schedule prescribed by your doctor is(( to be written by a healthcare professional )) ・In general, for adults, subcutaneously inject 1 kit (50 mg of the active ingredient) once a day, once a week. Strictly follow the instructions. ・The contents of a kit should be used al Read the complete document